Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases-Reference-Cited by-同舟云学术

Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases

Published:2022-05-11 Issue:10 Volume:65 Page:7170-7192
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Armani Elisabetta¹^ORCID,Capaldi Carmelida¹,Bagnacani Valentina¹,Saccani Francesca¹,Aquino Giancarlo¹,Puccini Paola¹,Facchinetti Fabrizio¹,Martucci Cataldo¹,Moretto Nadia¹,Villetti Gino¹,Patacchini Riccardo¹,Civelli Maurizio¹,Hurley Chris²,Jennings Andrew²,Alcaraz Lilian²,Bloomfield Dawn²,Briggs Michael²,Daly Stephen²,Panchal Terry²,Russell Vince²,Wicks Sharon²,Finch Harry³,Fitzgerald Mary³,Fox Craig³,Delcanale Maurizio¹

Affiliation:

1. Chiesi Farmaceutici S.p.A, Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy

2. Charles River Laboratories, 8/9 Spire Green Centre, Flex Meadow, Harlow CM19 5TR, United Kingdom

3. Pulmagen Therapeutics, The Coach House, Grenville Court Britwell Road, Burnham, Slough SL1 8DF, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00115

Reference32 articles.

1. Differential Expression and Activation of p38 Mitogen-Activated Protein Kinase α, β, γ, and δ in Inflammatory Cell Lineages